Texas Health Chief Tapped for Top CDC Role Amid Agency Turmoil

ARLINGTON, VA – April 17, 2026 – Dr. Jennifer Shuford, the respected commissioner of the Texas Department of State Health Services, has been appointed to serve as the new Deputy Director and Chief Medical Officer for the Centers for Disease Control and Prevention (CDC). The move installs a seasoned state-level administrator and infectious disease physician into a critical federal post at a time when the nation's premier public health agency is grappling with a severe leadership crisis and internal disarray.

The appointment was met with strong praise from public health organizations, including the Association of State and Territorial Health Officials (ASTHO), where Dr. Shuford serves as a board member.

"We applaud the appointment of Dr. Shuford to serve as deputy director and chief medical officer for CDC," said ASTHO CEO Joseph Kanter, MD, MPH, in a statement. "She is widely respected within the public health and governmental leadership communities. Her experience leading one of the nation's largest and most complex state health agencies—particularly her work as a frontline infectious disease physician and chief state epidemiologist—makes her uniquely qualified to help lead CDC."

A Crisis-Tested Leader for a Troubled Agency

Dr. Shuford steps into a CDC that has been hollowed out by leadership instability. Recent reports indicate that as many as 80% of the agency's top director positions are vacant, creating significant bureaucratic delays and breaks in critical data collection. The very role Shuford is filling—Deputy Director for Program and Science/Chief Medical Officer—has been empty since the resignation of Dr. Debra Houry in August 2025.

Dr. Houry's departure was a significant blow, as she publicly cited "an erosion of our science and the data and a lack of trust in it" under the current Health and Human Services (HHS) leadership. This followed the tumultuous ousting of former CDC Director Susan Monarez after less than a month in the role. The resulting leadership vacuum has reportedly led to plummeting staff morale and a slowing of agency productivity.

Against this backdrop, Dr. Shuford's appointment is being viewed by many public health experts as a crucial step toward stabilization. Her extensive track record in managing large-scale public health emergencies in Texas is seen as the exact experience needed to navigate the CDC's current challenges.

From the Frontlines of Texas Public Health

During her tenure as commissioner and, before that, as Chief State Epidemiologist, Dr. Shuford was at the helm of Texas's response to several major health crises. She was instrumental in guiding the state's public health efforts during the COVID-19 pandemic, where she oversaw initiatives to improve the speed and clarity of data provided to the public and policymakers.

More recently, she led the state's response to a massive measles outbreak in 2025, the nation's largest in three decades, which infected over 750 people and resulted in two tragic child deaths. In response, her agency allocated over $10 million for vaccination clinics and a public awareness campaign, with Dr. Shuford publicly championing the measles vaccine as a highly effective preventive measure. Her steadfast, evidence-based approach during that crisis stands in stark contrast to the concerns over politicization that have recently plagued federal health agencies.

Beyond infectious disease outbreaks, Dr. Shuford has also focused on long-term public health issues, championing initiatives to combat rising rates of congenital syphilis by ensuring pregnant women receive mandated screenings and effective treatment. Her leadership of the Texas DSHS, an agency with over 3,500 employees and a multibillion-dollar budget, has given her deep experience in both crisis management and the daily work of health promotion.

Bridging the Federal-State Divide

One of the most significant assets Dr. Shuford brings to the CDC is her intimate understanding of the complex and often fraught relationship between federal public health agencies and their state and local counterparts. The U.S. public health system is a patchwork of jurisdictions with varying levels of funding and resources, and federal guidance can sometimes fail to account for the on-the-ground realities of implementation.

Dr. Shuford has lived in that reality. Her experience navigating federal-state collaboration from the state side positions her uniquely to build bridges and improve coordination. This expertise was specifically highlighted by ASTHO's CEO.

"Dr. Shuford understands the vital relationship between federal, state, local, territorial and tribal public health departments," Kanter noted. "We are confident that her clinical expertise and proven track record in crisis management and health promotion will be invaluable assets to CDC and the nation."

Her perspective will be particularly valuable as the CDC continues its push for data modernization. Having worked to streamline data collection in Texas, she is well aware of the interoperability challenges that can hinder rapid outbreak responses and is poised to help shape federal strategies that are more effective and collaborative.

A Clinician's Expertise at the Helm

Beyond her administrative and leadership skills, Dr. Shuford's deep clinical and scientific background is central to her qualifications. She received her Doctor of Medicine from the University of Texas Southwestern Medical School, completed an infectious disease fellowship at the prestigious Mayo Clinic, and earned a Master of Public Health from Harvard.

This background as a frontline infectious disease physician provides a crucial clinical perspective for the role of Chief Medical Officer. It ensures that the agency's scientific and programmatic direction is grounded not only in population-level data but also in the practical realities of disease prevention and patient care. In an era of emerging pathogens and evolving health threats, having a leader with her specific expertise is seen as a vital asset for maintaining the CDC's scientific integrity and its role as a global leader in public health.

As Dr. Shuford transitions from the Texas statehouse to the national stage, she carries the weight of high expectations. For an agency in need of stability, scientific credibility, and strong leadership, her appointment is a significant development. Public health professionals across the country will be watching closely, hopeful that her unique blend of state-level pragmatism and deep scientific expertise can help restore the CDC to its position as the gold standard of public health.